222 related articles for article (PubMed ID: 28438778)
1. The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.
Hjuler ST; Gydesen S; Andreassen KV; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2017 Jul; 362(1):24-30. PubMed ID: 28438778
[TBL] [Abstract][Full Text] [Related]
2. The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy.
Larsen AT; Sonne N; Andreassen KV; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2020 Jul; 374(1):74-83. PubMed ID: 32317372
[TBL] [Abstract][Full Text] [Related]
3. A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats.
Andreassen KV; Feigh M; Hjuler ST; Gydesen S; Henriksen JE; Beck-Nielsen H; Christiansen C; Karsdal MA; Henriksen K
Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E24-33. PubMed ID: 24801386
[TBL] [Abstract][Full Text] [Related]
4. Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.
Feigh M; Andreassen KV; Neutzsky-Wulff AV; Petersen ST; Hansen C; Bay-Jensen AC; Henriksen JE; Beck-Nielsen H; Christiansen C; Henriksen K; Karsdal MA
Br J Pharmacol; 2012 Sep; 167(1):151-63. PubMed ID: 22506938
[TBL] [Abstract][Full Text] [Related]
5. TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats.
Ito R; Tsujihata Y; Matsuda-Nagasumi K; Mori I; Negoro N; Takeuchi K
Br J Pharmacol; 2013 Oct; 170(3):568-80. PubMed ID: 23848179
[TBL] [Abstract][Full Text] [Related]
6. The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile.
Larsen AT; Gydesen S; Sonne N; Karsdal MA; Henriksen K
BMC Endocr Disord; 2021 Jan; 21(1):10. PubMed ID: 33413317
[TBL] [Abstract][Full Text] [Related]
7. Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin.
Melander SA; Katri A; Karsdal MA; Henriksen K
Eur J Pharmacol; 2023 Jan; 938():175397. PubMed ID: 36414113
[TBL] [Abstract][Full Text] [Related]
8. Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats.
Melander SA; Møller AL; Mohamed KE; Rasmussen DGK; Genovese F; Karsdal MA; Henriksen K; Larsen AT
Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E529-E539. PubMed ID: 37792041
[TBL] [Abstract][Full Text] [Related]
9. KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats.
Andreassen KV; Larsen AT; Sonne N; Mohamed KE; Karsdal MA; Henriksen K
Mol Metab; 2021 Nov; 53():101282. PubMed ID: 34214708
[TBL] [Abstract][Full Text] [Related]
10. Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight.
Melander SA; Larsen AT; Karsdal MA; Henriksen K
Br J Pharmacol; 2024 Jun; 181(12):1829-1842. PubMed ID: 38378168
[TBL] [Abstract][Full Text] [Related]
11. Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats.
Gowda N; Dandu A; Singh J; Biswas S; Raghav V; Lakshmi MN; Shilpa PC; Sunil V; Reddy A; Sadasivuni M; Aparna K; Verma MK; Moolemath Y; Anup MO; Venkataranganna MV; Somesh BP; Jagannath MR
BMC Pharmacol Toxicol; 2013 May; 14():28. PubMed ID: 23692921
[TBL] [Abstract][Full Text] [Related]
12. Does receptor balance matter? - Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models.
Larsen AT; Mohamed KE; Sonne N; Bredtoft E; Andersen F; Karsdal MA; Henriksen K
Biomed Pharmacother; 2022 Dec; 156():113842. PubMed ID: 36242844
[TBL] [Abstract][Full Text] [Related]
13. Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss.
Larsen AT; Melander SA; Sonne N; Bredtoft E; Al-Rubai M; Karsdal MA; Henriksen K
Biomed Pharmacother; 2023 Aug; 164():114969. PubMed ID: 37269811
[TBL] [Abstract][Full Text] [Related]
14. The Dual Amylin and Calcitonin Receptor Agonist KBP-088 Induces Weight Loss and Improves Insulin Sensitivity Superior to Chronic Amylin Therapy.
Larsen AT; Sonne N; Andreassen KV; Gehring K; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2019 Jul; 370(1):35-43. PubMed ID: 31028106
[TBL] [Abstract][Full Text] [Related]
15. Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes.
Tajima A; Hirata T; Taniguchi K; Kondo Y; Kato S; Saito-Hori M; Ishimoto T; Yamamoto K
Life Sci; 2011 Oct; 89(17-18):662-70. PubMed ID: 21872612
[TBL] [Abstract][Full Text] [Related]
16. Treatment sequencing using the dual amylin and calcitonin receptor agonist KBP-336 and semaglutide results in durable weight loss.
Thorsø Larsen A; Karsdal MA; Henriksen K
Eur J Pharmacol; 2023 Sep; 954():175837. PubMed ID: 37329973
[TBL] [Abstract][Full Text] [Related]
17. Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats.
Reimer RA; Grover GJ; Koetzner L; Gahler RJ; Lyon MR; Wood S
J Endocrinol; 2014 Mar; 220(3):361-73. PubMed ID: 24389593
[TBL] [Abstract][Full Text] [Related]
18. The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action.
Sonne N; Larsen AT; Andreassen KV; Karsdal MA; Henriksen K
J Pharmacol Exp Ther; 2020 Apr; 373(1):92-102. PubMed ID: 31992608
[TBL] [Abstract][Full Text] [Related]
19. A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.
Gydesen S; Hjuler ST; Freving Z; Andreassen KV; Sonne N; Hellgren LI; Karsdal MA; Henriksen K
Br J Pharmacol; 2017 Apr; 174(7):591-602. PubMed ID: 28109166
[TBL] [Abstract][Full Text] [Related]
20. The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity.
Hjuler ST; Gydesen S; Andreassen KV; Pedersen SL; Hellgren LI; Karsdal MA; Henriksen K
Obesity (Silver Spring); 2016 Aug; 24(8):1712-22. PubMed ID: 27296301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
